Boothbay Fund Management’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-298,960
| Closed | -$2.98M | – | 2192 |
|
|
2022
Q2 | $2.98M | Buy |
298,960
+93,050
| +45% | +$927K | 0.08% | 345 |
|
|
2022
Q1 | $2.04M | Buy |
205,910
+40,019
| +24% | +$397K | 0.05% | 479 |
|
|
2021
Q4 | $1.67M | Sell |
165,891
-17,115
| -9% | -$173K | 0.04% | 453 |
|
|
2021
Q3 | $1.81M | Buy |
183,006
+227
| +0.1% | +$2.25K | 0.05% | 389 |
|
|
2021
Q2 | $1.86M | Buy |
182,779
+3,200
| +2% | +$32.6K | 0.06% | 347 |
|
|
2021
Q1 | $2.01M | Sell |
179,579
-51,561
| -22% | -$577K | 0.08% | 251 |
|
|
2020
Q4 | $2.96M | Sell |
231,140
-26,113
| -10% | -$335K | 0.11% | 141 |
|
|
2020
Q3 | $2.83M | Buy |
+257,253
| New | +$2.83M | 0.17% | 120 |
|